Case-crossover study to examine the change ...
Document type :
Article dans une revue scientifique: Article original
PMID :
Permalink :
Title :
Case-crossover study to examine the change in postpartum risk of pulmonary embolism over time
Author(s) :
Ficheur, Gregoire [Auteur]
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
Caron, Alexandre [Auteur]
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
BEUSCART, Jean-Baptiste [Auteur]
METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
Ferret, Laurie [Auteur]
Université de Lille
Jung, Yu-Jin [Auteur]
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
Garabedian, Charles [Auteur]
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
Beuscart, Regis [Auteur]
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
Chazard, Emmanuel [Auteur]
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]

Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
Caron, Alexandre [Auteur]
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
BEUSCART, Jean-Baptiste [Auteur]

METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
Ferret, Laurie [Auteur]
Université de Lille
Jung, Yu-Jin [Auteur]
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
Garabedian, Charles [Auteur]

Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
Beuscart, Regis [Auteur]
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
Chazard, Emmanuel [Auteur]

Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
Journal title :
BMC pregnancy and childbirth
Abbreviated title :
BMC Pregnancy Childbirth
Volume number :
17
Publication date :
2017-04-14
ISSN :
1471-2393
English keyword(s) :
Mesh:Case-Control Studies
Mesh:Young Adult
Mesh:Risk Factors
Mesh:Pulmonary Embolism/epidemiology*
Mesh:Puerperal Disorders/epidemiology*
Mesh:Pregnancy Complications
Mesh:Cardiovascular/epidemiology*
Mesh:Pregnancy
Mesh:Adult
Mesh:Odds Ratio
Mesh:Female
Mesh:Humans
Mesh:France/epidemiology
Mesh:Population Surveillance
Mesh:Young Adult
Mesh:Risk Factors
Mesh:Pulmonary Embolism/epidemiology*
Mesh:Puerperal Disorders/epidemiology*
Mesh:Pregnancy Complications
Mesh:Cardiovascular/epidemiology*
Mesh:Pregnancy
Mesh:Adult
Mesh:Odds Ratio
Mesh:Female
Mesh:Humans
Mesh:France/epidemiology
Mesh:Population Surveillance
HAL domain(s) :
Sciences du Vivant [q-bio]
English abstract : [en]
Although the current guidelines recommend anticoagulation up until 6 weeks after delivery in women at high risk of venous thromboembolism (VTE), the risk of VTE may extend beyond 6 weeks. Our objective was to estimate the ...
Show more >Although the current guidelines recommend anticoagulation up until 6 weeks after delivery in women at high risk of venous thromboembolism (VTE), the risk of VTE may extend beyond 6 weeks. Our objective was to estimate the risk of a pulmonary embolism in successive 2-week intervals during the postpartum period. In a population-based, case-crossover study, we analyzed the French national inpatient database from 2007 to 2013 (n = 5,517,680 singleton deliveries). Using ICD-10 codes, we identified women who were diagnosed with a postpartum pulmonary embolism between July 1stst We identified 167,103 cases with a pulmonary embolism during the inclusion period. After delivery, the risk of pulmonary embolism declined progressively over time, with an OR [95%CI] of 17.2 [14.0-21.3] in postpartum weeks 1 to 2 and 1.9 [1.4-2.7] in postpartum weeks 11 to 12. The OR [95%CI] in postpartum weeks 13 to 14 was 1.4 [0.9-2.0], and the OR did not fall significantly after postpartum week 14. Our findings indicate that women are at risk of a pulmonary embolism up to 12 weeks after delivery. The shape of the risk curve suggests that the risk decreases exponentially over time. Future research is needed to establish whether the duration of postpartum anticoagulation should be extended beyond 6 weeks.Show less >
Show more >Although the current guidelines recommend anticoagulation up until 6 weeks after delivery in women at high risk of venous thromboembolism (VTE), the risk of VTE may extend beyond 6 weeks. Our objective was to estimate the risk of a pulmonary embolism in successive 2-week intervals during the postpartum period. In a population-based, case-crossover study, we analyzed the French national inpatient database from 2007 to 2013 (n = 5,517,680 singleton deliveries). Using ICD-10 codes, we identified women who were diagnosed with a postpartum pulmonary embolism between July 1stst We identified 167,103 cases with a pulmonary embolism during the inclusion period. After delivery, the risk of pulmonary embolism declined progressively over time, with an OR [95%CI] of 17.2 [14.0-21.3] in postpartum weeks 1 to 2 and 1.9 [1.4-2.7] in postpartum weeks 11 to 12. The OR [95%CI] in postpartum weeks 13 to 14 was 1.4 [0.9-2.0], and the OR did not fall significantly after postpartum week 14. Our findings indicate that women are at risk of a pulmonary embolism up to 12 weeks after delivery. The shape of the risk curve suggests that the risk decreases exponentially over time. Future research is needed to establish whether the duration of postpartum anticoagulation should be extended beyond 6 weeks.Show less >
Language :
Anglais
Audience :
Internationale
Popular science :
Non
Administrative institution(s) :
CHU Lille
Université de Lille
Université de Lille
Submission date :
2019-12-09T16:54:55Z
2020-04-03T09:02:03Z
2020-04-03T09:02:03Z
Files
- s12884-017-1283-y.pdf
- Version éditeur
- Open access
- Access the document